In the first quarter, billionaires David Shaw and Louis Bacon sold Apple and bought O’Reilly Automotive, a stock-split stock ...

Zscaler's AI progress, especially in agentic tech, shows promise, but slowing growth and overvaluation raise concerns. See ...

Dividend-paying stocks have beaten the market. That doesn’t mean that income funds will do best ...

UK equities are staging a comeback, but there’s still plenty of value out there, says Rupert Hargreaves UK equities are having their time in the sun. The FTSE 100 recently hit an all-time high of ...

McKesson reported strong FY25 growth, plans spin-off to focus on oncology and biopharma. MCK is an undervalued stock upgraded ...

Investors are increasingly shifting to ethical stocks, not only for the sake of value alignment, but also to shield ...

William Blair analysts lowered their rating on Ameriprise stock to Market Perform from Outperform Friday following the financial services firm’s second-quarter report.

The S&P 500 was edging up by 0.1% in early trading, coming off its latest all-time high, and is on track to finish its fourth ...

U.S. stocks rose to more records as they capped another winning week. The S&P 500 climbed 0.4% to set an all-time high for ...

Second-quarter guidance called for its growth to slow.

Biopharmaceuticals stock Gilead Sciences (NASDAQ: GILD) jumped 2.5% through 12:30 p.m. ET Friday after Needham & Co. upgraded ...

The stock market continues its precarious ascent, navigating a “wall of worry” — a term that describes a rising market ...